Hematopoietic Neoplasm/Lymphoma - Miscellaneous

NCT06385483

Clinical Trial Information


Trial Number: NCT06385483 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol A: Phase II Trial of Afatinib in Patients With Solid Tumors (Other Than Small Cell and Non-Small Cell Lung Cancer) or Lymphomas, That Have Activating Mutations of EGFR and Have Progressed After Standard Treatment"
Study ID:
EAY131-A
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT06136897

Clinical Trial Information


Trial Number: NCT06136897 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol J: Trastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification"
Study ID:
EAY131-J
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT01382082

Clinical Trial Information


Trial Number: NCT01382082 (ClinicalTrials.gov)
Disease Type:
  • Breast Neoplasm - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
Trial Title:
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
Study ID:
URCC-10055
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT06303167

Clinical Trial Information


Trial Number: NCT06303167 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"MATCH Treatment Subprotocol E: Osimertinib (AZD9291) in Patients With Tumors Having EGFR T790M Mutations or Rare Activating Mutations of EGFR"
Study ID:
EAY131-E
Images are available?:
No
Is this a NCI-MATCH Trial?:
Yes


Datasets Linked to Trial

NCT06351371

Clinical Trial Information


Trial Number: NCT06351371 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Hematopoietic Neoplasm/Myeloma - Myeloma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol K2: Phase 2 Study of Erdafitinib (JNJ-42756493) in Patients With Tumors With FGFR Mutations or Fusions
Study ID:
EAY131-K2
Images are available?:
No
Is this a NCI-MATCH Trial?:
Yes


Datasets Linked to Trial

NCT06308822

Clinical Trial Information


Trial Number: NCT06308822 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Hematopoietic Neoplasm/Myeloma - Myeloma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol K1: Phase 2 Study of JNJ-42756493 (Erdafitinib) in Patients With Tumors With FGFR Amplifications
Study ID:
EAY131-K1
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT04439175

Clinical Trial Information


Trial Number: NCT04439175 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol I: GDC-0032 (taselisib) in Patients with Tumors (other than breast cancer) with PIK3CA mutation but without KRAS mutation or PTEN loss
Study ID:
EAY131-I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT04439201

Clinical Trial Information


Trial Number: NCT04439201 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol Z1B: Phase II Study of Palbociclib (PD-0332991) in Patients with Tumors with CCND1, 2, 3 Amplification
Study ID:
EAY131-Z1B
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT04439136

Clinical Trial Information


Trial Number: NCT04439136 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol B: Phase II Study of Afatinib in Patients With Tumors With HER2 Activating Mutations
Study ID:
EAY131-B
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT04439357

Clinical Trial Information


Trial Number: NCT04439357 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients With Tumors With GNAQ or GNA11 Mutations
Study ID:
EAY131-S2
Images are available?:
No
Is this a NCI-MATCH Trial?:
Yes


Datasets Linked to Trial

Subscribe to Hematopoietic Neoplasm/Lymphoma - Miscellaneous

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®